Marian Kruszynski

1.1k total citations · 1 hit paper
31 papers, 926 citations indexed

About

Marian Kruszynski is a scholar working on Social Psychology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Marian Kruszynski has authored 31 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Social Psychology, 9 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Marian Kruszynski's work include Neuroendocrine regulation and behavior (11 papers), Electrolyte and hormonal disorders (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Marian Kruszynski is often cited by papers focused on Neuroendocrine regulation and behavior (11 papers), Electrolyte and hormonal disorders (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Marian Kruszynski collaborates with scholars based in United States, Poland and Slovakia. Marian Kruszynski's co-authors include Wilbur H. Sawyer, Janny Seto, Bernard Lammek, Jaya Haldar, Maurice Manning, Wieslaw A. Kliś, Aleksandra Olma, M. Manning, Nga Ching Wo and W. H. Sawyer and has published in prestigious journals such as Nature, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Marian Kruszynski

31 papers receiving 857 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin

1980 417 citations Marian Kruszynski, Bernard Lammek et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marian Kruszynski United States	13	617	303	244	203	185	31	926
Maurice Manning United States	12	475 0.8×	280 0.9×	186 0.8×	135 0.7×	152 0.8×	25	650
S Gilbert United States	8	391 0.6×	641 2.1×	143 0.6×	330 1.6×	185 1.0×	8	893
M. C. Harris United Kingdom	13	282 0.5×	106 0.3×	320 1.3×	56 0.3×	154 0.8×	29	634
Dominic Devost Canada	22	232 0.4×	639 2.1×	151 0.6×	35 0.2×	352 1.9×	43	1.1k
Martha J. Fernström United States	9	496 0.8×	213 0.7×	175 0.7×	93 0.5×	85 0.5×	10	901
Nick Ling United States	16	174 0.3×	322 1.1×	155 0.6×	16 0.1×	200 1.1×	17	1.1k
Katja Bürger Germany	13	109 0.2×	618 2.0×	72 0.3×	26 0.1×	244 1.3×	23	1.2k
Vincenzo Guarcello United States	15	58 0.1×	282 0.9×	42 0.2×	33 0.2×	152 0.8×	31	872
Motoaki Tomioka Canada	10	49 0.1×	208 0.7×	56 0.2×	133 0.7×	285 1.5×	13	983
Christophe Grundschober Switzerland	14	124 0.2×	90 0.3×	179 0.7×	19 0.1×	53 0.3×	19	641

Countries citing papers authored by Marian Kruszynski

Since Specialization

Citations

This map shows the geographic impact of Marian Kruszynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marian Kruszynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marian Kruszynski more than expected).

Fields of papers citing papers by Marian Kruszynski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marian Kruszynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marian Kruszynski. The network helps show where Marian Kruszynski may publish in the future.

Co-authorship network of co-authors of Marian Kruszynski

This figure shows the co-authorship network connecting the top 25 collaborators of Marian Kruszynski. A scholar is included among the top collaborators of Marian Kruszynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marian Kruszynski. Marian Kruszynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teplyakov, A., Galina Obmolova, Nicole Stowell, et al.. (2010). Synthesis by native chemical ligation and crystal structure of human CCL2. Biopolymers. 94(3). 350–359. 10 indexed citations

Brezski, Randall J., Jennifer L. Luongo, Mary Ryan, et al.. (2008). Human Anti-IgG1 Hinge Autoantibodies Reconstitute the Effector Functions of Proteolytically Inactivated IgGs. The Journal of Immunology. 181(5). 3183–3192. 38 indexed citations

Kruszynski, Marian, Nicole Stowell, Anuk Das, et al.. (2005). Synthesis and biological characterization of human monocyte chemoattractant protein 1 (MCP‐1) and its analogs. Journal of Peptide Science. 12(1). 25–32. 5 indexed citations

Kruszynski, Marian, Ping Tsui, Nicole Stowell, et al.. (2005). Synthetic, site-specific biotinylated analogs of human MCP-1. Journal of Peptide Science. 12(5). 354–360. 4 indexed citations

Knight, David, Robert E. Jordan, Marian Kruszynski, et al.. (2004). Pharmacodynamic enhancement of the anti-platelet antibody Fab abciximab by site-specific pegylation. Platelets. 15(7). 409–418. 19 indexed citations

Kruszynski, Marian, et al.. (1999). IDENTIFICATION OF TNF-α BINDING PEPTIDES FROM AD-AMINO ACID HEXAPEPTIDE LIBRARY THAT SPECIFICALLY INHIBIT TNF-α BINDING TO RECOMBINANT p55 RECEPTOR. Cytokine. 11(1). 37–44. 11 indexed citations

Kruszynski, Marian, Marian T. Nakada, Susan H. Tam, et al.. (1996). Determination of the Core Sequence of an Antagonist of Selectin-Dependent Leukocyte Adhesion and Correlation of Its Structure with Molecular Modeling Studies. Archives of Biochemistry and Biophysics. 331(1). 23–30. 2 indexed citations

Heavner, George A., et al.. (1993). Peptides from multiple regions of the lectin domain of P‐selectin inhibiting neutrophil adhesion. International journal of peptide & protein research. 42(5). 484–489. 14 indexed citations

Sawyer, W. H., et al.. (1991). Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position. Cellular and Molecular Life Sciences. 47(1). 83–86. 1 indexed citations

10.

Kruszynski, Marian, M. Manning, Nga Ching Wo, & W. H. Sawyer. (1990). Invertebrate neuropeptides resembling vasotocin and some analogues: Synthesis and pharmacological properties. Cellular and Molecular Life Sciences. 46(7). 771–773. 7 indexed citations

11.

Manning, Maurice, Stoytcho Stoev, ALEKSANDER KOLODZIEJCZYK, et al.. (1990). Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin. Journal of Medicinal Chemistry. 33(11). 3079–3086. 34 indexed citations

12.

Manning, Maurice, Marian Kruszynski, Krzysztof Bańkowski, et al.. (1989). Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin. Journal of Medicinal Chemistry. 32(2). 382–391. 101 indexed citations

13.

Sawyer, W. H., K. Bańkowski, Aleksandra Misicka, et al.. (1988). Potent V2 vasopressin antagonists with structural changes at their C-terminals. Peptides. 9(1). 157–163. 23 indexed citations

14.

Bańkowski, Krzysztof, Bernard Lammek, Marian Kruszynski, et al.. (1988). 2-O-methyl and 2-O-ethyl-tyrosine derivatives of [8-arginine]vasopressin analogs: Highly specific antidiuretic agonists. Collection of Czechoslovak Chemical Communications. 53(11). 2617–2626. 3 indexed citations

15.

Manning, M., Wieslaw A. Kliś, Marian Kruszynski, et al.. (1988). Novel linear antagonists of the antidiuretic (V₂) and vasopressor (V₁) responses to vasopressin. International journal of peptide & protein research. 32(6). 455–467. 22 indexed citations

16.

Wiczk, Wiesław, et al.. (1988). Distribution of distances in thiopeptides by fluorescence energy transfer and frequency-domain fluorometry. Biophysical Chemistry. 32(1). 43–49. 8 indexed citations

17.

Manning, M., Jacek Przybylski, Aleksandra Olma, et al.. (1987). No requirement of cyclic conformation of antagonists in binding to vasopressin receptors. Nature. 329(6142). 839–840. 62 indexed citations

18.

Manning, M., Aleksandra Misicka, Aleksandra Olma, et al.. (1987). C-Terminal deletions in antagonistic analogs of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors. Journal of Medicinal Chemistry. 30(12). 2245–2252. 25 indexed citations

19.

Manning, Maurice, Bernard Lammek, Marian Kruszynski, Janny Seto, & Wilbur H. Sawyer. (1982). Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin. Journal of Medicinal Chemistry. 25(4). 408–414. 31 indexed citations

20.

Kruszynski, Marian, Bernard Lammek, Maurice Manning, et al.. (1980). [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin. Journal of Medicinal Chemistry. 23(4). 364–368. 417 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact